Cervical lesion drug trial halted early
NCT ID NCT05502367
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a vaginal insert called ABI-2280 in women with cervical precancerous lesions (CIN). The goal was to see if it was safe and could help clear the abnormal cells. The trial was stopped early, so we don't have full results. It involved 44 women aged 25-55 who used the insert themselves.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ABI-2280 vaginal insert
What this could lead to
If it had worked, this could point toward a non-surgical treatment for cervical precancerous lesions.
What could go wrong
The trial was terminated early, so we don't have clear results. It was also a small, early-phase study, so success was never guaranteed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botho ke Bontle Health Services
Waltloo, Gauteng, 0184, South Africa
-
CerviCusco
Cusco, Peru
-
East Sydney Doctors
Darlinghurst, New South Wales, 2010, Australia
-
Farmovs
Bloemfontein, Free State, 9301, South Africa
-
Ginobs S.A.
Lima, Peru
-
Gole Biomedical Research Centre
Ga-Mothapo, Limpopo, South Africa
-
Nafasi Integrated Solutions
Sunnyside, Gauteng, 0002, South Africa